Aprotinin (13 Citations)
Catalog
Description
Size
Price(USD)
Qty
Catalog
786-1245
786-1245
Description
Aprotinin
Aprotinin
Size
25 mg
25 mg
$128.00
$128.00
Catalog
786-046
786-046
Description
Aprotinin
Aprotinin
Size
100mg
100mg
$382.00
$382.00
Also known as bovine pancreatic trypsin inhibitor.
Activity: Approx 6,000 KIU/mg
Specificity: A broad range, competitive and reversible inhibitor of chymotrypsin, plasmin, trypsin, kallikrein and other serine proteases
Solubility: Soluble in water (Stock solution: 10mM)
A globular, monomeric protein chain. The sequence is RPDFC LEPPY TGPCK ARIIR YFYNA KAGLC QTFVY GGCRA KRNNF KSAED CMRTC GGA
Ki Constants:
Enzyme | Ki [M] |
Trypsin, bovine | 6x10-14 |
Trypsinogen, bovine | 1.8x10-6 |
Chymotrypsin, bovine | 9x10-9 |
Plasmin, humna | 2.3x10-10 |
Kallikrein, pancreatic porcine | 1x10-9 |
Elastase, leukocytes human | 3.5x10-6 |
Urokinase, single chain | 27x10-6 |
Urokinase, two chain | 25x10-6 |
Features
- Synonym: Trypsin inhibitor
- CAS#: 9087-70-1
- Molecular Formula: C284H432N84O79S7
- Molecular Weight: 6512
Material Safety Data Sheet | |
786-1245 | |
786-046 |
Technical Literature | |
Protease & Phosphatase Inhibitors & Proteases Handbook | A handbook & selection guide for inhibitors of protease & phosphatases & for proteases & assays |
Certificate Of Analysis | |
786-1245 | |
786-046 |
- Rawal, Manpreet Kaur et al (2021) Newly identified motifs in Candida albicans Cdr1 protein nucleotide binding domains are pleiotropic drug reistance subfamily-specific and functionally asymmetric. SCI REP-UK. https://doi.org/10.1038/srep27132
- Si, L. et al (2021) A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylatics. NAT BIOMED ENG. https://doi.org/10.1038/s41551-021-00718-9
- Zhao, N. et al ( 2016) Neogenin Facilitates the Induction of Hepcidin Expression by Hemojuvelin in the Liver.J. Biol. Chem. 2016; 291:12322-12335.
- Beussman, K. M. et al (2015) Methods. DOI: 10.1016/j.ymeth.2015.09.005
- Beussman, K.M. et al (2015) Micropost arrays for measuring stem-cell derived cardiomyocyte contractility. Methods doi.org/10.1016/j.ymeth.2015.09.005
- Shah, A.H. et al (2015) Scientific Reports. 5:11211
- Labouesse, M.A. et al (2014) Bone. 64:138
- Marlatt, V.L. et al (2014) Gen Comp Endocr. 203:203
- Rodriguez, M. L. et al (2014) J. Biomech. Eng. 136:1381
- Marlatt, V.L. et al (2013) Comp. Biochem. Phys. C. 157:24
- Murphy, M.M and Michael, W.M. (2013) JBC. 288: 29382
- Rodriguez, A. et al (2011) Biophys. J. 101:2455